Evotec SE
ISIN
DE0005664809
Ticker
EVT
Sector
Sub-Industry
Country
Germany
Year Founded
1993
ISIN
DE0005664809
Ticker
EVT
Sector
Sub-Industry
Country
Germany
Year Founded
1993
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
3,030
Worldwide
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 03.05.2024 | Dohrmann, Dr. Cord | Board | Other | EUR 76,220.10 |
| 12.02.2024 | Dohrmann, Dr. Cord | Board | Sell | EUR 272,025.13 |
| 22.01.2024 | Lanthaler, Dr. Werner | Board | Sell | EUR 397,543.19 |
| 18.01.2024 | Lanthaler, Dr. Werner | Board | Other | EUR 159,141.96 |
| 18.01.2024 | Lanthaler, Dr. Werner | Board | Other | EUR 131,792.04 |
| 18.01.2024 | Dohrmann, Dr. Cord | Board | Other | EUR 87,387.85 |
| 18.01.2024 | Johnstone, Dr. Craig | Board | Other | EUR 51,611.51 |
| 18.01.2024 | Johnstone, Dr. Craig | Board | Other | EUR 51,596.02 |
| 18.01.2024 | Johnstone, Dr. Craig | Board | Other | EUR 42,730.20 |
| 18.01.2024 | Johnstone, Dr. Craig | Board | Other | EUR 42,715.44 |
DE0005664809
529900F9KI6OYITO9B12
Oddo BHF Corporates & Markets AG
MDAX
TecDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.